(Q39665248)

English

Divergent rifamycin susceptibilities of Clostridium difficile strains in Canada and Italy and predictive accuracy of rifampin Etest for rifamycin resistance

scientific article published on 12 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Divergent rifamycin susceptibilities of Clostridium difficile strains in Canada and Italy and predictive accuracy of rifampin Etest for rifamycin resistance (English)

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

0 references

0 references

Clostridium difficile

0 references

1 reference

based on heuristic

inferred from title

Fabrizio Barbanti

object named as

Fabrizio Barbanti

4

0 references

Patrizia Spigaglia

object named as

Patrizia Spigaglia

3

0 references

Paola Mastrantonio

5

object named as

Paola Mastrantonio

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

author name string

Mark A Miller

1

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Ruth Blanchette

2

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

language of work or name

0 references

publication date

12 October 2011

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Journal of Clinical Microbiology

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

49

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

12

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

4319-4321

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Fidaxomicin versus vancomycin for Clostridium difficile infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

14 September 2017

Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

14 September 2017

High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

14 September 2017

Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

14 September 2017

Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

14 September 2017

In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

14 September 2017

In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

14 September 2017

An epidemic, toxin gene-variant strain of Clostridium difficile

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

14 September 2017

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

14 September 2017

Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

14 September 2017

Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

14 September 2017

Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

14 September 2017

Structural mechanism for rifampicin inhibition of bacterial rna polymerase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

14 September 2017

In vitro activity and fecal concentration of rifaximin after oral administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

14 September 2017

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

14 September 2017

Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

25 September 2017

Pulsed-field gel electrophoresis can yield DNA fingerprints of degradation-susceptible Clostridium difficile strains

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

17 June 2018

In vitro susceptibility of Clostridium difficile to rifaximin and rifampin in 359 consecutive isolates at a university hospital in Houston, Texas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

21 August 2018

Emergence of reduced susceptibility to metronidazole in Clostridium difficile

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

21 August 2018

Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233014

21 August 2018

Treatment of clostridium difficile infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21998414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rifaximin (L/105), a new topical intestinal antibiotic: pharmacokinetic study after single oral administration of 3H-rifaximin to rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/21998414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High dosage rifaximin for the treatment of small intestinal bacterial overgrowth

1 reference

https://pubmed.ncbi.nlm.nih.gov/21998414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of Death afterClostridium difficileInfection: A Report on 128 Strain‐Typed Cases from a Teaching Hospital in the United Kingdom

1 reference

https://pubmed.ncbi.nlm.nih.gov/21998414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/JCM.05100-11

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39665248&oldid=1852801840"